Learn more

VERNALIS R & D LTD

Overview
  • Total Patents
    139
  • GoodIP Patent Rank
    184,595
About

VERNALIS R & D LTD has a total of 139 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are JENKEN BIOSCIENCES INC, VERNALIS CAMBRIDGE LTD and B C I PHARMA.

Patent filings per year

Chart showing VERNALIS R & D LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Stokes Stephen 23
#2 Drysdale Martin James 20
#3 Bedford Simon 17
#4 Brough Paul Andrew 16
#5 Drysdale Martin 16
#6 Brough Paul 14
#7 Gillespie Roger John 13
#8 Macias Alba 10
#9 Todd Richard Simon 10
#10 Lynch Rosemary 10

Latest patents

Publication Filing date Title
WO2015040425A1 Resorcinol n-aryl amide compounds, for use as pyruvate dehydrogenase kinase inhibitors
WO2015040424A1 Tetrahydroisoquinoline compounds and their use as pyruvate dehydrogenase kinase inhibitors
GB201201566D0 New chemical compounds
GB201019598D0 New chemical compounds
GB0912499D0 Indopyl-pyridone derivatives
GB0906579D0 Pharmaceuticals, compositions and methods of making and using the same
CN102015635A Azetidine derivatives
CN101970424A Indolyl- pyridone derivatives having checkpoint kinase 1 inhibitory activity
GB0821694D0 Azetidine derivatives
GB0821708D0 New chemical compounds
GB0821485D0 Azetidine Dervatives
GB0818695D0 New chemical compounds
GB0807056D0 Enzyme inhibitors
GB0804006D0 Azetidine derivatives
GB0801090D0 New chemical compounds
GB0718432D0 New chemical compounds
GB0718433D0 New chemical compounds
GB0718434D0 New chemical compounds
WO2009030871A1 Pyrrolopyrimidine derivatives having hsp90 inhibitory activity
GB0706853D0 Enzyme inhibitors